Peter Schirmacher is Pathologist and Molecular Pathologist and Director of the Institute of Pathology of Heidelberg University and Coordinator of the Liver Cancer Center Heidelberg (LCCH), the Center for Personalized Medicine (ZPM) Heidelberg, and the BioMaterialBank Heidelberg (BMBH). Peter Schirmacher’s research interest centers around Liver Pathology, Liver Carcinogenesis and Molecular Mechanisms of Tumor Development. He has published more than 850 papers including Journals, such as Cell, Science, Nature, Nat Med, Gastroenterology, Hepatology, J Hep and Gut and has been member of numerous editorial boards, including J Hep and Hepatology. He has been coordinator of several large research consortia, expecially on liver cancer (e.g. SFB/TR79 (2010-15) and SFB/TR209 (2017-23)) and has been member of many national and international (EASL, ESMO) boards of liver-related clinical guidelines. He is expert member of the editorial board of the WHO Tumor Classification (5th and 6th edition)